News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cardiovascular Biotech Celladon Corporation Sets Terms for $75 Million IPO


11/4/2013 8:02:58 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Celladon, which is developing novel therapies for the treatment of heart disease, announced terms for its IPO on Friday. The San Diego, CA-based company plans to raise $75 million by offering 5.0 million shares at a price range of $14 to $16. At the midpoint of the proposed range, Celladon would command a market value of $257 million.

Help employers find you! Check out all the jobs and post your resume.

Read at Nasdaq

comments powered by Disqus
Nasdaq
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES